Peter N. Strong

2.7k total citations
66 papers, 2.2k citations indexed

About

Peter N. Strong is a scholar working on Molecular Biology, Genetics and Microbiology. According to data from OpenAlex, Peter N. Strong has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 32 papers in Genetics and 11 papers in Microbiology. Recurrent topics in Peter N. Strong's work include Venomous Animal Envenomation and Studies (29 papers), Ion channel regulation and function (25 papers) and Muscle Physiology and Disorders (17 papers). Peter N. Strong is often cited by papers focused on Venomous Animal Envenomation and Studies (29 papers), Ion channel regulation and function (25 papers) and Muscle Physiology and Disorders (17 papers). Peter N. Strong collaborates with scholars based in United Kingdom, Egypt and United States. Peter N. Strong's co-authors include Mohamed A. Abdel-Rahman, Keith Miller, Patrick L. Harrison, Victor Dubowitz, T G Sherratt, Stephen G. Oberg, Caroline A. Sewry, Neil A. Castle, R B Kelly and Jon Goerke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Peter N. Strong

66 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter N. Strong United Kingdom 28 1.8k 869 384 304 296 66 2.2k
Frank Bosmans Belgium 31 2.5k 1.4× 1.3k 1.4× 844 2.2× 374 1.2× 213 0.7× 73 3.1k
Yucheng Xiao China 23 1.4k 0.8× 613 0.7× 442 1.2× 142 0.5× 93 0.3× 58 1.8k
Lachlan D. Rash Australia 29 2.2k 1.2× 1.3k 1.4× 529 1.4× 53 0.2× 401 1.4× 58 3.0k
M. Pelhate France 32 1.9k 1.1× 1.3k 1.5× 1.0k 2.6× 177 0.6× 107 0.4× 90 3.0k
Pierre Charnet France 31 2.8k 1.6× 291 0.3× 1.4k 3.7× 713 2.3× 213 0.7× 98 3.5k
Christina I. Schroeder Australia 32 2.3k 1.3× 355 0.4× 421 1.1× 43 0.1× 305 1.0× 103 2.8k
Michel Ronjat France 29 2.1k 1.2× 425 0.5× 625 1.6× 622 2.0× 169 0.6× 77 2.5k
Samuel D. Robinson Australia 21 1.1k 0.6× 429 0.5× 334 0.9× 40 0.1× 172 0.6× 78 1.6k
Katherine J. Nielsen Australia 17 1.2k 0.7× 197 0.2× 220 0.6× 36 0.1× 127 0.4× 22 1.3k
Jeff J. Clare United Kingdom 20 1.7k 0.9× 123 0.1× 601 1.6× 211 0.7× 26 0.1× 31 2.1k

Countries citing papers authored by Peter N. Strong

Since Specialization
Citations

This map shows the geographic impact of Peter N. Strong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. Strong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. Strong more than expected).

Fields of papers citing papers by Peter N. Strong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. Strong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. Strong. The network helps show where Peter N. Strong may publish in the future.

Co-authorship network of co-authors of Peter N. Strong

This figure shows the co-authorship network connecting the top 25 collaborators of Peter N. Strong. A scholar is included among the top collaborators of Peter N. Strong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter N. Strong. Peter N. Strong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haywood‐Small, Sarah, et al.. (2022). Scorpion Venom Antimicrobial Peptides Induce Caspase-1 Dependant Pyroptotic Cell Death. Frontiers in Pharmacology. 12. 788874–788874. 18 indexed citations
2.
Clark, Graeme C., Nicholas R. Casewell, Christopher T. Elliott, et al.. (2019). Friends or Foes? Emerging Impacts of Biological Toxins. Trends in Biochemical Sciences. 44(4). 365–379. 45 indexed citations
3.
Harrison, Patrick L., George R. Heath, Benjamin Johnson, et al.. (2016). Phospholipid dependent mechanism of smp24, an α-helical antimicrobial peptide from scorpion venom. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(11). 2737–2744. 30 indexed citations
4.
Chai, Sergio C., Arunmozhiarasi Armugam, Peter N. Strong, & Kandiah Jeyaseelan. (2012). Charaterization of bumarsin, a 3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitor from Mesobuthus martensii Karsch venom. Toxicon. 60(3). 272–279. 8 indexed citations
5.
Abdel-Rahman, Mohamed A., et al.. (2011). Intraspecific variation in the venom of the vermivorous cone snail Conus vexillum. Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology. 154(4). 318–325. 30 indexed citations
6.
Pedarzani, Paola, Dieter D’hoedt, Jonathan D. F. Wadsworth, et al.. (2002). Tamapin, a Venom Peptide from the Indian Red Scorpion (Mesobuthus tamulus) That Targets Small Conductance Ca2+-activated K+ Channels and Afterhyperpolarization Currents in Central Neurons. Journal of Biological Chemistry. 277(48). 46101–46109. 83 indexed citations
7.
Montagna, P., Rocco Liguori, L. Monari, et al.. (2001). Equine muscular dystrophy with myotonia. Clinical Neurophysiology. 112(2). 294–299. 21 indexed citations
8.
Bevan, Stuart, et al.. (1997). A Novel Small Conductance Ca2+-activated K+ Channel Blocker from Oxyuranus scutellatusTaipan Venom. Journal of Biological Chemistry. 272(32). 19925–19930. 20 indexed citations
9.
Fassati, Ariberto, Dominic J. Wells, F S Walsh, et al.. (1997). Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.. Journal of Clinical Investigation. 100(3). 620–628. 29 indexed citations
10.
Strong, Peter N., et al.. (1993). Identification of a Protein Product of the Myotonic Dystrophy Gene Using Peptide-Specific Antibodies. Biochemical and Biophysical Research Communications. 194(3). 1256–1260. 23 indexed citations
11.
Sewry, Caroline A., Angela Clerk, T G Sherratt, et al.. (1993). Manifesting carriers of Xp21 muscular dystrophy; Lack of correlation between dystrophin expression and clinical weakness. Neuromuscular Disorders. 3(2). 141–148. 26 indexed citations
12.
Clerk, Angela, Caroline A. Sewry, Victor Dubowitz, & Peter N. Strong. (1992). Characterisation of dystrophin in fetuses at risk for Duchenne muscular dystrophy. Journal of the Neurological Sciences. 111(1). 82–91. 10 indexed citations
13.
Torelli, Silvia, Valeria Sogos, Maria Grazia Ennas, et al.. (1992). Dystrophin immunoreactivity in normal and duchenne human fetal neurons in culture. Journal of Neuroscience Research. 32(1). 116–125. 17 indexed citations
14.
Sewry, C., Angela Clerk, J Z Heckmatt, et al.. (1991). Dystrophin abnormalities in polymyositis and dermatomyositis. Neuromuscular Disorders. 1(5). 333–339. 12 indexed citations
15.
Patel, K., Peter N. Strong, Victor Dubowitz, & Michael J. Dünn. (1988). Calmodulin‐binding profiles for nebulin and dystrophin in human skeletal muscle. FEBS Letters. 234(2). 267–271. 10 indexed citations
16.
Hawgood, Barbara J., Iona Smith, & Peter N. Strong. (1988). Early induction by crotoxin of biphasic frequency changes and giant miniature endplate potentials in frog muscle. British Journal of Pharmacology. 94(3). 765–772. 14 indexed citations
17.
Anderson, A.J., A.L. Harvey, Edward G. Rowan, & Peter N. Strong. (1988). Effects of charybdotoxin, a blocker of Ca2+ ‐activated K + channels, on motor nerve terminals. British Journal of Pharmacology. 95(4). 1329–1335. 63 indexed citations
18.
Radvanyi, François, B. Saliou, Cassian Bon, & Peter N. Strong. (1987). The interaction between the presynaptic phospholipase neurotoxins beta-bungarotoxin and crotoxin and mixed detergent-phosphatidylcholine micelles. A comparison with non-neurotoxic snake venom phospholipases A2.. Journal of Biological Chemistry. 262(19). 8966–8974. 34 indexed citations
19.
Caratsch, C. G., Bruno Maranda, Ricardo Miledi, & Peter N. Strong. (1982). Antibodies to β-bungarotoxin and its phospholipase inactive derivative. Proceedings of the Royal Society of London. Series B, Biological sciences. 215(1200). 365–373. 7 indexed citations
20.
Strong, Peter N., Jon Goerke, Stephen G. Oberg, & R B Kelly. (1976). beta-Bungarotoxin, a pre-synaptic toxin with enzymatic activity.. Proceedings of the National Academy of Sciences. 73(1). 178–182. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026